[go: up one dir, main page]

JP2003344413A - Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method - Google Patents

Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method

Info

Publication number
JP2003344413A
JP2003344413A JP2002151415A JP2002151415A JP2003344413A JP 2003344413 A JP2003344413 A JP 2003344413A JP 2002151415 A JP2002151415 A JP 2002151415A JP 2002151415 A JP2002151415 A JP 2002151415A JP 2003344413 A JP2003344413 A JP 2003344413A
Authority
JP
Japan
Prior art keywords
group
general formula
sensitivity enhancer
methacrylate
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002151415A
Other languages
Japanese (ja)
Other versions
JP3911200B2 (en
Inventor
Hideaki Takao
英明 高尾
Jun Suzuoki
純 鈴置
Masaaki Kida
正章 木田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd, NOF Corp filed Critical Wako Pure Chemical Industries Ltd
Priority to JP2002151415A priority Critical patent/JP3911200B2/en
Publication of JP2003344413A publication Critical patent/JP2003344413A/en
Application granted granted Critical
Publication of JP3911200B2 publication Critical patent/JP3911200B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

(57)【要約】 【課題】 梅毒関連抗体から選ばれるものを
測定対象物質とする、従来公知のイムノクロマト測定感
度増強剤に比較して、より強い感度増強効果が得られる
ものを提供する。 【解決手段】 (1)下記一般式[1] 【化1】 (式中、R〜Rは夫々独立して水素原子又は水酸基
を有していてもよいアルキル基を示し、Rはアルキレ
ン基を示す。)で表される基を側鎖に有するポリマーを
含んでなる、梅毒関連抗体から選ばれるものを測定対象
物質とするイムノクロマト測定法用感度増強剤。(2)
一般式[1]で表される基を側鎖に有するポリマーの存
在下に抗原抗体反応を行わせることを特徴とする、梅毒
関連抗体ら選ばれるものを測定対象物質とするイムノク
ロマト測定法。(3)(1)の感度増強剤を含んでな
る、梅毒関連抗体から選ばれるものを測定対象物質とす
るイムノクロマト測定法用器具。
(57) [Problem] To provide a substance capable of obtaining a stronger sensitivity enhancement effect as compared with a conventionally known immunochromatographic sensitivity enhancer using a substance selected from syphilis-related antibodies as a measurement target substance. (1) The following general formula [1] (Wherein R 1 to R 3 each independently represents a hydrogen atom or an alkyl group optionally having a hydroxyl group, and R 4 represents an alkylene group). A sensitivity enhancer for an immunochromatographic assay using a substance selected from syphilis-related antibodies, comprising: (2)
An immunochromatographic measurement method using a substance selected from syphilis-related antibodies as an object of measurement, wherein an antigen-antibody reaction is carried out in the presence of a polymer having a group represented by the general formula [1] in its side chain. (3) An instrument for an immunochromatographic measurement method comprising a substance selected from syphilis-related antibodies, comprising the sensitivity enhancer of (1).

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、梅毒関連抗体を測
定対象物質とするイムノクロマト測定法に於ける感度増
強剤、当該感度増強剤の共存下で行う、梅毒関連抗体を
測定対象物質とするイムノクロマト測定法並びに当該感
度増強剤を含有してなる、梅毒関連抗体を測定対象物質
とするイムノクロマト測定法用器具に関する。
TECHNICAL FIELD The present invention relates to a sensitivity enhancer in an immunochromatographic assay using an syphilis-related antibody as a substance to be measured, and an immunochromatography using the syphilis-related antibody as a substance to be measured in the presence of the sensitivity enhancer. The present invention relates to a measurement method and an instrument for immunochromatography measurement, which comprises the sensitizer for syphilis and contains the sensitivity enhancer.

【0002】[0002]

【従来の技術】イムノクロマト法は、多孔質膜の毛細管
現象を利用したクロマトグラフィーの手法と免疫学的手
法を組み合わせた方法であり、迅速且つ簡便に、そして
特別な器具を用いることなく免疫測定を行える方法であ
り、各種抗原や抗体の検出等に用いられている。
2. Description of the Related Art The immunochromatographic method is a method that combines a chromatographic method utilizing the capillary phenomenon of a porous membrane and an immunological method, and is a quick and simple method for immunoassay without using a special instrument. It is a method that can be performed and is used for detection of various antigens and antibodies.

【0003】しかしながら、この方法は、簡易に測定で
きる代わりに感度の精度が低く、陽性検体を用いても偽
陰性と判定される場合もあり、より高い感度のイムノク
ロマト測定法が望まれていた。
However, this method has a low sensitivity accuracy in spite of the fact that it can be easily measured, and it may be judged as a false negative even if a positive sample is used, and an immunochromatographic measurement method with higher sensitivity has been desired.

【0004】[0004]

【発明が解決しようとする課題】本発明の第1の目的
は、従来のものと比較し、より精度が優れたイムノクロ
マト用感度増強剤を提供することにある。また、本発明
の第2の目的は、前記イムノクロマト用感度増強剤を用
いた測定法を提供することにある。また更に、本発明の
第3の目的は、前記感度増強剤を含んでなるイムノクロ
マト測定法用器具を提供するものである。
SUMMARY OF THE INVENTION A first object of the present invention is to provide a sensitivity enhancer for immunochromatography, which is more accurate than conventional ones. A second object of the present invention is to provide a measuring method using the sensitivity enhancer for immunochromatography. Still further, a third object of the present invention is to provide an instrument for immunochromatographic assay containing the above-mentioned sensitivity enhancer.

【0005】[0005]

【課題を解決するための手段】本発明者らは、このよう
な現状に鑑み、鋭意検討した結果、本発明がなされたも
のである。即ち、本発明者等は、梅毒関連抗体を測定対
象物質とする免疫学的測定法に於ける、公知の感度増強
剤に比較して、より強い感度増強効果を有する化合物を
見出すべく鋭意研究の結果、上記一般式[1]で示され
る、ホスホベタイン構造を有する基を側鎖に有するポリ
マーが目的の性能を有していることを見出し、本発明を
完成するに至った。その手段として以下のものを提供す
るものである。
The present inventors have made the present invention as a result of intensive studies in view of such a current situation. That is, the present inventors, in an immunological assay method using a syphilis-related antibody as a substance to be measured, compared with known sensitivity enhancers, are keenly researched to find a compound having a stronger sensitivity enhancing effect. As a result, they have found that a polymer represented by the above general formula [1] and having a group having a phosphobetaine structure in its side chain has desired performance, and completed the present invention. The following are provided as the means.

【0006】(1)下記一般式[1](1) The following general formula [1]

【化7】 [Chemical 7]

【0007】(式中、R〜Rは夫々独立して水素原
子又は水酸基を有していてもよいアルキル基を示し、R
はアルキレン基を示す。)で表される基を側鎖に有す
るポリマーを含んでなる、梅毒関連抗体を測定対象物質
とするイムノクロマト測定法用感度増強剤。
(In the formula, R 1 to R 3 each independently represent a hydrogen atom or an alkyl group which may have a hydroxyl group;
4 represents an alkylene group. ) A sensitivity enhancer for immunochromatographic assay, which comprises a polymer having a group represented by the formula (1) as a side chain, and a syphilis-related antibody as a measurement target substance.

【0008】(2)一般式[1]で表される基を側鎖に
有するポリマーの存在下に抗原抗体反応を行わせること
を特徴とする、梅毒関連抗体を測定対象物質とするイム
ノクロマト測定法。
(2) An immunochromatographic assay method in which an syphilis-related antibody is used as a substance to be measured, characterized in that an antigen-antibody reaction is carried out in the presence of a polymer having a group represented by the general formula [1] in its side chain. .

【0009】(3)(1)の感度増強剤を含んでなる、
梅毒関連抗体を測定対象物質とするイムノクロマト測定
法用器具。
(3) comprising the sensitivity enhancer of (1),
Instrument for immunochromatographic assay using syphilis-related antibody as the measurement target substance.

【0010】[0010]

【発明の実施の形態】本発明に於いて、感度増強剤とし
て用いられるポリマーは、上記一般式[1]で表される
基を側鎖に有するものであればよく、ホモポリマーでも
コポリマーでも特に限定されないが、通常分子量が10,0
00〜1,000,000、好ましくは10,000〜500,000、より好ま
しくは50,000〜500,000である。
BEST MODE FOR CARRYING OUT THE INVENTION In the present invention, the polymer used as a sensitivity enhancer may be any polymer having a group represented by the above general formula [1] in its side chain, and may be a homopolymer or a copolymer. Normally, but not limited to, a molecular weight of 10,0
It is from 00 to 1,000,000, preferably from 10,000 to 500,000, more preferably from 50,000 to 500,000.

【0011】より具体的には、下記一般式[2]More specifically, the following general formula [2]

【化8】 [Chemical 8]

【0012】(式中、Rは、置換基を有していてもよ
く且つ鎖中に酸素原子を有していてもよいアルキレン基
を示し、Rは水素原子又はメチル基を示し、Xは酸素
原子又は−NH−基を示し、R〜Rは前記に同
じ。)で表されるモノマーに基づく構成単位に基づく構
成単位を有するものが好ましく挙げられる。
(In the formula, R 5 represents an alkylene group which may have a substituent and may have an oxygen atom in the chain, R 6 represents a hydrogen atom or a methyl group, and X represents Represents an oxygen atom or an -NH- group, and R 1 to R 4 are preferably the same as those described above).

【0013】上記一般式[1]又は[2]に於いて、R
〜Rで示される水酸基を有していてもよいアルキル
基のアルキル基としては、直鎖状、分枝状、環状の何れ
でもよく、通常炭素数1〜6、好ましくは1〜4、より
好ましくは1〜2、更に好ましくは1のものが挙げら
れ、具体的には、例えばメチル基、エチル基、n-プロピ
ル基、イソプロピル基、n-ブチル基、イソブチル基、se
c-ブチル基、tert-ブチル基、n-ペンチル基、イソペン
チル基、sec-ペンチル基、tert-ペンチル基、n-ヘキシ
ル基、イソヘキシル基、sec-ヘキシル基、tert-ヘキシ
ル基、シクロプロピル基、シクロヘキシル基、シクロペ
ンチル基等が挙げられ、好ましくはメチル基、エチル基
等であり、より好ましくはメチル基等である。
In the above general formula [1] or [2], R
The alkyl group of the alkyl group which may have a hydroxyl group represented by 1 to R 3 may be linear, branched or cyclic, and usually has 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms. More preferably, one or more, and more preferably one is mentioned, and specifically, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, se
c-butyl group, tert-butyl group, n-pentyl group, isopentyl group, sec-pentyl group, tert-pentyl group, n-hexyl group, isohexyl group, sec-hexyl group, tert-hexyl group, cyclopropyl group, Examples thereof include a cyclohexyl group and a cyclopentyl group, preferably a methyl group, an ethyl group and the like, more preferably a methyl group and the like.

【0014】また、水酸基を有するアルキル基として
は、上記した如きアルキル基の水素原子の1〜2個、好
ましくは1個が水酸基に置換したものが挙げられ、具体
的には、例えばヒドロキシメチル基、ヒドロキシエチル
基、ヒドロキシ-n-プロピル基、ヒドロキシイソプロピ
ル基、ヒドロキシ-n-ブチル基、ヒドロキシ-イソブチル
基、ヒドロキシ-sec-ブチル基、ヒドロキシ-tert-ブチ
ル基、ヒドロキシ-n-ペンチル基、ヒドロキシ-イソペン
チル基、ヒドロキシ-sec-ペンチル基、ヒドロキシ-tert
-ペンチル基、ヒドロキシ-n-ヘキシル基、ヒドロキシ-
イソヘキシル基、ヒドロキシ-sec-ヘキシル基、ヒドロ
キシ-tert-ヘキシル基、ヒドロキシ-シクロプロピル
基、ヒドロキシ-シクロヘキシル基、ヒドロキシ-シクロ
ペンチル基等が挙げられ、好ましくはヒドロキシメチル
基、ヒドロキシエチル基等である。
Examples of the alkyl group having a hydroxyl group include those in which 1 to 2, preferably 1 of the hydrogen atoms of the alkyl group as described above are substituted with a hydroxyl group. Specifically, for example, a hydroxymethyl group. , Hydroxyethyl group, hydroxy-n-propyl group, hydroxyisopropyl group, hydroxy-n-butyl group, hydroxy-isobutyl group, hydroxy-sec-butyl group, hydroxy-tert-butyl group, hydroxy-n-pentyl group, hydroxy -Isopentyl group, hydroxy-sec-pentyl group, hydroxy-tert
-Pentyl group, hydroxy-n-hexyl group, hydroxy-
Examples thereof include an isohexyl group, a hydroxy-sec-hexyl group, a hydroxy-tert-hexyl group, a hydroxy-cyclopropyl group, a hydroxy-cyclohexyl group and a hydroxy-cyclopentyl group, and a hydroxymethyl group and a hydroxyethyl group are preferable.

【0015】Rで示されるアルキレン基としては、例
えば炭素数1〜6、好ましくは2〜3のものが挙げら
れ、これらは直鎖状、分枝状、環状の何れでもよい。具
体的には、例えばメチレン基、エチレン基、プロピレン
基、トリメチレン基、ブチレン基、1−エチルエチレン
基、2−メチルトリメチレン基、2−エチルトリメチレ
ン基、へキシレン基、シクロプロピレン基、シクロブチ
レン基、シクロペンチレン基、シクロへキシレン基等が
挙げられ、好ましくはエチレン基、プロピレン基、トリ
メチレン基等である。
Examples of the alkylene group represented by R 4 include those having 1 to 6 carbon atoms, preferably 2 to 3 carbon atoms, which may be linear, branched or cyclic. Specifically, for example, methylene group, ethylene group, propylene group, trimethylene group, butylene group, 1-ethylethylene group, 2-methyltrimethylene group, 2-ethyltrimethylene group, hexylene group, cyclopropylene group, cyclo Examples thereof include a butylene group, a cyclopentylene group, and a cyclohexylene group, and an ethylene group, a propylene group, a trimethylene group and the like are preferable.

【0016】一般式[2]に於いてRで表される、置
換基を有していてもよく且つ鎖中に酸素原子を有してい
てもよいアルキレン基において、酸素を有さない場合の
アルキレン基としては、例えば炭素数1〜10、好まし
くは1〜6、より好ましくは2〜6のものが挙げられ、
これらは直鎖状、分枝状、環状の何れでもよい。具体的
には、例えばメチレン基、エチレン基、プロピレン基、
トリメチレン基、ブチレン基、1−エチルエチレン基、
2−メチルトリメチレン基、2−エチルトリメチレン
基、へキシレン基、シクロプロピレン基、シクロブチレ
ン基、シクロペンチレン基、シクロへキシレン基等が挙
げられる。また、その置換基としては、例えば炭素数1
〜6、好ましくは1〜3のアルコキシル基〔直鎖状、分
枝状、環状の何れにてもよい。〕、より具体的には例え
ばメトキシ基、エトキシ基、n-プロポキシ基、イソプロ
ポキシ基、n-ブトキシ基、イソブトキシ基、sec-ブトキ
シ基、tert-ブトキシ基、n-ペンチルオキシ基、イソペ
ンチルオキシ基、sec-ペンチルオキシ基、tert-ペンチ
ルオキシ基、n-ヘキシルオキシ基、イソヘキシルオキシ
基、sec-ヘキシルオキシ基、tert-ヘキシルオキシ基、
シクロプロポキシ基、シクロヘキシルオキシ基、シクロ
ペンチルオキシ基等、例えばハロゲン原子、より具体的
にはフッ素原子、塩素原子、臭素原子、ヨウ素原子等が
挙げられ、好ましくはエチレン基、プロピレン基、トリ
メチレン基、ブチレン基等である。また、鎖中に酸素原
子を有する場合、酸素原子としては1〜5個、好ましく
は1〜3個であり、より具体的には−(C24O)n
24−(式中、nは1〜5の整数を表す。)等が挙げ
られる。上記したRで表される、置換基を有していて
もよく且つ鎖中に酸素原子を有していてもよいアルキレ
ン基の中でも、エチレン基、プロピレン基が好ましく、
エチレン基がより好ましい。
In the alkylene group represented by R 5 in the general formula [2], which may have a substituent and may have an oxygen atom in the chain, does not have oxygen. Examples of the alkylene group include, for example, those having 1 to 10 carbon atoms, preferably 1 to 6 carbon atoms, more preferably 2 to 6 carbon atoms,
These may be linear, branched or cyclic. Specifically, for example, a methylene group, an ethylene group, a propylene group,
Trimethylene group, butylene group, 1-ethylethylene group,
Examples thereof include a 2-methyltrimethylene group, a 2-ethyltrimethylene group, a hexylene group, a cyclopropylene group, a cyclobutylene group, a cyclopentylene group, and a cyclohexylene group. In addition, the substituent has, for example, 1 carbon atom.
To 6, preferably 1 to 3 alkoxyl groups (which may be linear, branched or cyclic. ] More specifically, for example, methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group, n-pentyloxy group, isopentyloxy group. Group, sec-pentyloxy group, tert-pentyloxy group, n-hexyloxy group, isohexyloxy group, sec-hexyloxy group, tert-hexyloxy group,
Cyclopropoxy group, cyclohexyloxy group, cyclopentyloxy group and the like, for example, halogen atom, more specifically, fluorine atom, chlorine atom, bromine atom, iodine atom and the like, preferably ethylene group, propylene group, trimethylene group, butylene. Group etc. Also, if having an oxygen atom in the chain, 1-5 as an oxygen atom, preferably one to three, more specifically - (C 2 H 4 O) n -
C 2 H 4 - (wherein, n represents an integer of 1 to 5.), And the like. Among the alkylene groups represented by R 5 which may have a substituent and may have an oxygen atom in the chain, ethylene group and propylene group are preferable,
Ethylene groups are more preferred.

【0017】本発明に係る一般式[1]で示される基を
側鎖に有するモノマーに基づく構成単位を有するポリマ
ーは、市販されているものを用いてもよいし、例えば特
開平10−45794号公報、特開2000−2396
96号公報等に記載された方法に準じて合成されたもの
を用いてもよい。
As the polymer having a structural unit derived from a monomer having a group represented by the general formula [1] in the side chain according to the present invention, a commercially available polymer may be used, for example, JP-A-10-45794. Japanese Patent Laid-Open No. 2000-2396
Those synthesized according to the method described in Japanese Patent Publication No. 96 etc. may be used.

【0018】上記一般式[2]で表されるモノマーに基
づく構成単位としては、上記した如きR1〜R6を有する
ものであればよいが、具体的には例えば下記一般式
[5]
The constitutional unit based on the monomer represented by the general formula [2] may be any unit having R 1 to R 6 as described above, and specifically, for example, the following general formula [5]

【0019】[0019]

【化9】 [Chemical 9]

【0020】で表されるモノマーに基づく構成単位等が
挙げられる。
Examples include constitutional units based on the monomer represented by

【0021】本発明に係る一般式[2]で表されるモノ
マーに基づく構成単位を有するポリマーがコポリマーで
ある場合、上記一般式[2]で表されるモノマーに基づ
く構成単位以外のモノマー単位としては、アクリル酸又
はアクリル酸エステル、メタクリル酸又はメタクリル酸
エステル、アクリルアミド又はそのN置換体、メタクリ
ルアミド又はそのN置換体、或いはスチレン又はその誘
導体から選ばれるモノマー由来のものが挙げられる。
尚、これらモノマー単位は、コポリマー中に2種類以上
含まれていてもよい。また、コポリマーにおける、一般
式[2]で表されるモノマーにに基づく構成単位の比率
は、通常20%以上100%未満であり、好ましくは3
0〜95%であり、より好ましくは30〜90%であ
る。
When the polymer having a constitutional unit based on the monomer represented by the general formula [2] according to the present invention is a copolymer, as a monomer unit other than the constitutional unit based on the monomer represented by the general formula [2]. Is derived from a monomer selected from acrylic acid or acrylic acid ester, methacrylic acid or methacrylic acid ester, acrylamide or its N-substituted product, methacrylamide or its N-substituted product, or styrene or its derivative.
Two or more kinds of these monomer units may be contained in the copolymer. The ratio of the structural unit based on the monomer represented by the general formula [2] in the copolymer is usually 20% or more and less than 100%, preferably 3%.
It is 0 to 95%, more preferably 30 to 90%.

【0022】上記一般式[2]で表されるモノマーに基
づく構成単位以外のモノマー単位としてのアクリル酸エ
ステルとしては、アルキルアクリレート、アラルキルア
クリレート等が、メタクリル酸エステルとしては、アル
キルメタクリレート、アラルキルメタクリレート等が挙
げられ、アクリルアミドのN置換体は、N−アルキルア
クリルアミド又はN−アラルキルアクリルアミドであ
り、メタクリルアミドのN置換体は、N−アルキルメタ
クリルアミド又はN−アラルキルメタクリルアミドであ
り、スチレン誘導体としては、α−メチルスチレン、置
換基を有するスチレン又はα−メチルスチレン等が挙げ
られる。
Alkyl acrylate, aralkyl acrylate and the like are used as the acrylic acid ester as a monomer unit other than the constitutional unit based on the monomer represented by the general formula [2], and as the methacrylic acid ester, alkyl methacrylate and aralkyl methacrylate are used. The N-substituted acrylamide is N-alkylacrylamide or N-aralkylacrylamide, the N-substituted methacrylamide is N-alkylmethacrylamide or N-aralkylmethacrylamide, and the styrene derivative is Examples thereof include α-methylstyrene, styrene having a substituent and α-methylstyrene.

【0023】上記のアルキルアクリレート、アルキルメ
タクリレート、N−アルキルアクリルアミド及びN−ア
ルキルメタクリルアミドに於けるアルキル基としては、
直鎖状、分枝状、環状の何れでもよく、通常炭素数1〜
6、より好ましくは、1〜4のものが挙げられ、具体的
には、例えばメチル基、エチル基、n-プロピル基、イソ
プロピル基、n-ブチル基、イソブチル基、sec-ブチル
基、tert-ブチル基、n-ペンチル基、イソペンチル基、s
ec-ペンチル基、tert-ペンチル基、n-ヘキシル基、イソ
ヘキシル基、sec-ヘキシル基、tert-ヘキシル基、シク
ロプロピル基、シクロヘキシル基、シクロペンチル基等
が挙げられる。このアルキル基は置換基を有していても
よく、その置換基としては、例えばヒドロキシル基、炭
素数1〜3の低級アルコキシル基、トリアルキルアンモ
ニオ基(アルキル基としては、例えばメチル基、エチル
基、プロピル基、イソプロピル基等の炭素数1〜3のも
のが挙げられる。尚、置換基としてトリアルキルアンモ
ニオ基を有する場合、本置換基はプラスに荷電している
ため、通常カウンターアニオンが結合しているが、この
ようなカウンターアニオンとしては、フッ素イオン、塩
素イオン、臭素イオン、ヨウ素イオン等のハロゲン化物
イオン等が挙げられる。)等が挙げられる。また、置換
基を有するアルキル基としては、例えば以下のような基
The alkyl group in the above alkyl acrylate, alkyl methacrylate, N-alkyl acrylamide and N-alkyl methacrylamide includes
It may be linear, branched, or cyclic and usually has 1 to 1 carbon atoms.
6, more preferably, 1 to 4, specifically, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert- Butyl group, n-pentyl group, isopentyl group, s
Examples thereof include an ec-pentyl group, a tert-pentyl group, an n-hexyl group, an isohexyl group, a sec-hexyl group, a tert-hexyl group, a cyclopropyl group, a cyclohexyl group and a cyclopentyl group. This alkyl group may have a substituent, and examples of the substituent include a hydroxyl group, a lower alkoxyl group having 1 to 3 carbon atoms, and a trialkylammonio group (as the alkyl group, for example, a methyl group, an ethyl group). Groups having 1 to 3 carbon atoms such as a propyl group, an isopropyl group, an isopropyl group, etc. When the compound has a trialkylammonio group as a substituent, since this substituent is positively charged, a counter anion is usually present. Although bound, examples of such a counter anion include a fluoride ion, a chloride ion, a bromide ion, a halide ion such as an iodide ion, and the like). In addition, examples of the alkyl group having a substituent include the following groups.

【化10】 [Chemical 10]

【0024】(尚、Rは炭素数1〜3のアルキル基を
表し、mは1〜100を表す。)で表されるものも含ま
れる。
(Note that R 7 represents an alkyl group having 1 to 3 carbon atoms, and m represents 1 to 100).

【0025】また、アラルキルアクリレート、アラルキ
ルメタクリレート、N−アラルキルアクリルアミド及び
N−アラルキルメタクリルアミドに於けるアラルキル基
としては、炭素数7〜10のものが挙げられ、具体的に
は、例えばベンジル基、フェニルエチル基、フェニルプ
ロピル基、フェニルブチル基等が挙げられる。
Examples of the aralkyl group in aralkyl acrylate, aralkyl methacrylate, N-aralkyl acrylamide and N-aralkyl methacrylamide include those having 7 to 10 carbon atoms, and specific examples include benzyl group and phenyl group. Examples thereof include an ethyl group, a phenylpropyl group and a phenylbutyl group.

【0026】スチレン若しくはα−メチルスチレンが有
していてもよい置換基としては、例えば直鎖状、分枝
状、環状の、通常炭素数1〜6、より好ましくは1〜4
のアルキル基(具体的には、例えばメチル基、エチル
基、n-プロピル基、イソプロピル基、n-ブチル基、イソ
ブチル基、sec-ブチル基、tert-ブチル基、n-ペンチル
基、イソペンチル基、sec-ペンチル基、tert-ペンチル
基、n-ヘキシル基、イソヘキシル基、sec-ヘキシル基、
tert-ヘキシル基、シクロプロピル基、シクロヘキシル
基、シクロペンチル基等)、例えば直鎖状、分枝状、環
状の、通常炭素数1〜6、より好ましくは1〜4のアラ
ルキル基(具体的には、例えばメトキシ基、エトキシ
基、n-プロポキシ基、イソプロポキシ基、n-ブトキシ
基、イソブトキシ基、sec-ブトキシ基、tert-ブトキシ
基、n-ペンチルオキシ基、イソペンチルオキシ基、sec-
ペンチルオキシ基、tert-ペンチルオキシ基、n-ヘキシ
ルオキシ基、イソヘキシルオキシ基、sec-ヘキシルオキ
シ基、tert-ヘキシルオキシ基、シクロプロポキシ基、
シクロヘキシルオキシ基、シクロペンチルオキシ基
等)、例えばフッ素原子、塩素原子、臭素原子、ヨウ素
原子等のハロゲン原子、カルボキシル基、ヒドロキシ
基、アミノ基等が挙げられる。
The substituent which styrene or α-methylstyrene may have is, for example, linear, branched or cyclic, usually having 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms.
Alkyl group (specifically, for example, methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, isobutyl group, sec-butyl group, tert-butyl group, n-pentyl group, isopentyl group, sec-pentyl group, tert-pentyl group, n-hexyl group, isohexyl group, sec-hexyl group,
tert-hexyl group, cyclopropyl group, cyclohexyl group, cyclopentyl group, etc.), for example, linear, branched, or cyclic aralkyl group having usually 1 to 6 carbon atoms, more preferably 1 to 4 carbon atoms (specifically, , For example, methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, isobutoxy group, sec-butoxy group, tert-butoxy group, n-pentyloxy group, isopentyloxy group, sec-
Pentyloxy group, tert-pentyloxy group, n-hexyloxy group, isohexyloxy group, sec-hexyloxy group, tert-hexyloxy group, cyclopropoxy group,
Cyclohexyloxy group, cyclopentyloxy group and the like), for example, halogen atom such as fluorine atom, chlorine atom, bromine atom and iodine atom, carboxyl group, hydroxy group, amino group and the like.

【0027】上記一般式[2]で表されるモノマーに基
づく構成単位以外のモノマー単位の具体例としては、例
えばメタクリル酸、メタクリル酸メチル、メタクリル酸
エチル、メタクリル酸プロピル、メタクリル酸ブチル、
メタクリル酸ドデシル、メタクリル酸オクタデシル、メ
タクリル酸2-エチルヘキシル、メタクリル酸ラウリル、
メタクリル酸ステアリル、メタクリル酸2-トリメチルア
ンモニオエチル、メタクリル酸ベンジル、メタクリル酸
フェニルエチル、アクリル酸、アクリル酸メチル、アク
リル酸エチル、アクリル酸ブチル、アクリル酸2-エチル
ヘキシル、アクリル酸ラウリル、アクリル酸ステアリ
ル、アクリル酸2-トリメチルアンモニオエチル、アクリ
ル酸ベンジル、アクリル酸フェニルエチル、アクリルア
ミド、N−メチルアクリルアミド、N−エチルアクリル
アミド、N−ブチルアクリルアミド、N−2-エチルヘキ
シルアクリルアミド、N−ラウリルアクリルアミド、N
−ステアリルアクリルアミド、N−2-トリメチルアンモ
ニオエチルアクリルアミド、N−ベンジルアクリルアミ
ド、N−フェニルエチルアクリルアミド、メタクリルア
ミド、N−メチルメタクリルアミド、N−エチルメタク
リルアミド、N−ブチルメタクリルアミド、N−2-エチ
ルヘキシルメタクリルアミド、N−ラウリルメタクリル
アミド、N−ステアリルメタクリルアミド、N−2-トリ
メチルアンモニオエチルメタクリルアミド、N−ベンジ
ルメタクリルアミド、N−フェニルエチルメタクリルア
ミド、スチレン、カルボキシスチレン、ヒドロキシスチ
レン、アミノスチレン、メチルスチレン、エチルスチレ
ン、メトキシスチレン、エトキシスチレン、クロロスチ
レン、ブロモスチレン、α−メチルスチレン、α−メチ
ル−カルボキシスチレン、α−メチル−ヒドロキシスチ
レン、α−メチル−アミノスチレン、α−メチル−メチ
ルスチレン、α−メチル−エチルスチレン、α−メチル
−メトキシスチレン、α−メチル−エトキシスチレン、
α−メチル−クロロスチレン、α−メチル−ブロモスチ
レン、N,N,N-トリエチルアンモニウムエチルメタクリレ
ートブロミド、N,N,N-トリメチルアンモニウムエチルメ
タクリレートクロリド、N,N,-ジエチル−N−プロピル
アンモニウムエチルメタクリレートブロミド、N,N,N-ト
リメチルアンモニウム−2−ヒドロキシプロピルメタク
リレートクロリド(QM)、N,N,N-トリメチルアンモニ
ウムメチルスチレンブロミド等由来のものが挙げられ、
また、下記一般式[4]
Specific examples of the monomer unit other than the constitutional unit based on the monomer represented by the above general formula [2] include, for example, methacrylic acid, methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate,
Dodecyl methacrylate, octadecyl methacrylate, 2-ethylhexyl methacrylate, lauryl methacrylate,
Stearyl methacrylate, 2-trimethylammonioethyl methacrylate, benzyl methacrylate, phenylethyl methacrylate, acrylic acid, methyl acrylate, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate, lauryl acrylate, stearyl acrylate , 2-trimethylammonioethyl acrylate, benzyl acrylate, phenylethyl acrylate, acrylamide, N-methylacrylamide, N-ethylacrylamide, N-butylacrylamide, N-2-ethylhexylacrylamide, N-laurylacrylamide, N
-Stearyl acrylamide, N-2-trimethylammonioethyl acrylamide, N-benzyl acrylamide, N-phenyl ethyl acrylamide, methacrylamide, N-methyl methacrylamide, N-ethyl methacrylamide, N-butyl methacrylamide, N-2- Ethylhexyl methacrylamide, N-lauryl methacrylamide, N-stearyl methacrylamide, N-2-trimethylammonioethyl methacrylamide, N-benzyl methacrylamide, N-phenylethyl methacrylamide, styrene, carboxystyrene, hydroxystyrene, aminostyrene , Methylstyrene, ethylstyrene, methoxystyrene, ethoxystyrene, chlorostyrene, bromostyrene, α-methylstyrene, α-methyl-carboxystyrene Α-methyl-hydroxystyrene, α-methyl-aminostyrene, α-methyl-methylstyrene, α-methyl-ethylstyrene, α-methyl-methoxystyrene, α-methyl-ethoxystyrene,
α-Methyl-chlorostyrene, α-methyl-bromostyrene, N, N, N-triethylammonium ethyl methacrylate bromide, N, N, N-trimethylammonium ethyl methacrylate chloride, N, N, -diethyl-N-propylammonium ethyl Examples include those derived from methacrylate bromide, N, N, N-trimethylammonium-2-hydroxypropylmethacrylate chloride (QM), N, N, N-trimethylammonium methylstyrene bromide,
In addition, the following general formula [4]

【0028】[0028]

【化11】 [Chemical 11]

【0029】(式中、mは1〜100を表す。)で表さ
れるもの等も具体例として挙げられる。
Specific examples include those represented by the formula (wherein m represents 1 to 100).

【0030】上記した中でも、メタクリル酸、メタクリ
ル酸ステアリル、メタクリル酸ベンジル、メタクリル酸
ブチル、メタクリル酸ドデシル、メタクリル酸オクタデ
シルN,N,N-トリメチルアンモニウム−2−ヒドロキシプ
ロピルメタクリレートクロリド(QM)等由来のもの、
一般式[4]で表されるもの等が好ましい。
Among the above, methacrylic acid, stearyl methacrylate, benzyl methacrylate, butyl methacrylate, dodecyl methacrylate, octadecyl methacrylate N, N, N-trimethylammonium-2-hydroxypropylmethacrylate chloride (QM) and the like are used. thing,
Those represented by the general formula [4] are preferable.

【0031】本発明の感度増強剤は、上記した如き一般
式[1]で表される基を側鎖に有するポリマーを含んで
なるものであり、好ましくは一般式[2]で表されるモ
ノマーに基づく構成単位を有するポリマーである。該感
度増強剤は、イムノクロマト測定法に於いて用いられる
各種試薬や試料に溶解させて用いてもよく、また、イム
ノクロマト測定法用器具に担持させて用いてもよいが、
操作の簡便さから後者の方がより好ましい。
The sensitivity enhancer of the present invention comprises a polymer having a group represented by the general formula [1] as a side chain as described above, and preferably a monomer represented by the general formula [2]. A polymer having a structural unit based on The sensitivity enhancer may be used by dissolving it in various reagents or samples used in the immunochromatographic measuring method, or may be used by being carried on an instrument for the immunochromatographic measuring method.
The latter is more preferable because of the ease of operation.

【0032】本発明のイムノクロマト測定法で用いられ
るイムノクロマト測定法用器具としては、例えば(1)
展開膜からなるもの、(2)検体標識部並びに展開膜か
らなり、且つ該検体標識部と該展開膜とが毛管現象によ
り移動可能なように形成されたもの、(3)検体標識
部、展開膜並びに液体吸収部からなり、且つ該検体標識
部と該展開膜と該液体吸収部とが、この順に毛管現象に
より移動可能なように形成されたもの、(4)検体滴下
部、検体標識部、展開膜並びに液体吸収部からなり、且
つ該検体滴下部と該検体標識部と該展開膜と該液体吸収
部とが、この順に毛管現象により移動可能なように形成
されたもの等が挙げられる。
Examples of the immunochromatographic measuring instrument used in the immunochromatographic measuring method of the present invention include (1)
(2) A sample comprising a spreading film, (2) a sample labeling part and a spreading film, wherein the sample labeling part and the spreading film are formed so as to be movable by capillarity, (3) a sample labeling part, a development (4) A sample and a liquid absorbing part, wherein the sample labeling part, the spreading film and the liquid absorbing part are formed to be movable in this order by capillarity, (4) sample dropping part, sample labeling part , A spreading film and a liquid absorbing part, and the sample dropping part, the sample labeling part, the spreading film and the liquid absorbing part are formed so as to be movable in this order by capillarity. .

【0033】上記展開膜には測定部が設けられており、
当該測定部は、測定対象物質と結合能を有する物質(以
下、測定対象結合物質と略記する場合がある。)が固定
化されて担持された部分であり、数種の測定対象物質を
同時に測定する場合には、互いに重なりを持たないよう
に数種の測定対象結合物質が、展開膜上に、例えば線
状、或いはスポット状に固定化されて担持されてなる。
また、上記検体標識部は、標識された測定対象結合物質
を、毛管現象により移動可能な状態で保持してなるもの
であり、数種の測定対象物質を同時に測定する場合に
は、数種の標識された測定対象結合物質を、毛管現象に
より移動可能な状態でに保持してなる。さらに、検体滴
下部は、検体滴下用に展開膜又は検体標識部と重なるよ
うに形成される部位であり、液体吸収部は、検体の毛管
現象による移動をし易くするために設けられるものであ
り、展開膜に重なるように形成される部位を表す。
A measuring section is provided on the developed film,
The measurement part is a portion on which a substance having a binding ability to a measurement target substance (hereinafter, may be abbreviated as a measurement target binding substance) is immobilized and carried, and several types of measurement target substances are simultaneously measured. In such a case, several types of binding substances to be measured are supported and immobilized on the spreading film, for example, in a linear or spot form so that they do not overlap each other.
Further, the sample labeling unit is a labeled binding substance to be measured, which is held in a movable state by a capillary phenomenon, in the case of simultaneously measuring several types of measurement target substances, several types of The labeled binding substance to be measured is held in a movable state by a capillary phenomenon. Further, the sample dropping part is a part formed so as to overlap the spreading film or the sample labeling part for dropping the sample, and the liquid absorbing part is provided in order to facilitate the movement of the sample due to the capillarity. , Represents a site formed so as to overlap the developed film.

【0034】上記した如き器具は、市販品を用いても、
公知の方法により作製したものを用いてもよい。公知の
方法により作製する場合、上記展開膜で用いられる基材
としては、通常この分野で用いられるものを用いればよ
く、例えばセルロース、ニトロセルロース、ナイロン等
が好ましいものとして挙げられる。尚、上記検体標識
部、検体滴下部及び液体吸収部で用いられる基材も、こ
れらに準じたものを用いればよい。また、上記展開膜上
には、非特異的な吸着による測定への影響を防止するた
めに、所謂ブロッキング処理を施してもよい。このよう
なブロッキング処理は、通常この分野で用いられている
ブロッキング剤を通常この分野で行われる方法により行
えばよい。検体標識部に保持される標識された測定対象
結合物質としては、測定対象物質である抗体に対する抗
原に標識物質を担持させたもの等が挙げられる。その標
識物質としては、通常この分野で用いられているもので
あれ何れでもよいが、金コロイド、セレニウムコロイ
ド、着色ラテックス等の視覚的に検知し得るシグナルが
得られる標識物質が好ましく、特に取扱いのし易さや感
度等の点から金コロイドがより好ましい。上記した如き
標識物質は、常法により調製されたものを用いても、市
販品を用いてもよく、その使用濃度も、この分野で通常
用いられる濃度範囲で用いればよい。
Even if a commercially available product is used as the above instrument,
You may use what was produced by the well-known method. When produced by a known method, the base material used in the spreading film may be one usually used in this field, and preferred examples include cellulose, nitrocellulose, nylon and the like. The base material used in the sample labeling part, the sample dropping part, and the liquid absorbing part may be based on these. In addition, so-called blocking treatment may be performed on the developed film in order to prevent the influence of non-specific adsorption on the measurement. Such blocking treatment may be carried out by using a blocking agent which is usually used in this field, and a method which is usually used in this field. Examples of the labeled binding substance to be measured held in the sample labeling unit include those in which the labeling substance is carried on the antigen against the antibody as the measurement target substance. The labeling substance may be any of those usually used in this field, but a labeling substance such as a gold colloid, a selenium colloid, and a colored latex that can give a visually detectable signal is preferable, and particularly, it is Gold colloid is more preferable from the viewpoints of ease of operation and sensitivity. As the labeling substance as described above, a labeling substance prepared by a conventional method may be used, or a commercially available product may be used, and the concentration used may be within the concentration range usually used in this field.

【0035】本発明の感度増強剤を、イムノクロマト測
定法用器具に担持させて用いる場合、その量は、担持さ
れる場所、使用する感度増強剤の種類、使用する測定対
象物質の種類、使用する標識物質等により変動するが、
例えばイムノクロマト測定法用器具の展開膜、検体標識
部、検体滴下部等に担持させる場合、単位面積(cm2
当たりに含まれる感度増強剤の量として、通常0.01μg
〜10mg、好ましくは0.1μg〜4mg、より好ましくは
1〜800μgである。また、担持される面積は、用いられ
るイムノクロマト測定法用器具の種類及び大きさ、測定
用試料の量により変動するが、イムノクロマト測定法用
器具の展開膜の場合には、通常総面積の10〜60%、好ま
しくは20〜30%、検体標識部の場合には、通常総面積の
1〜30%、好ましくは5〜15%、検体滴下部の場合には、
通常総面積の5〜40%、好ましくは10〜20%である。ま
た、イムノクロマト測定法用器具に於いて担持される部
位としては、測定用試料と接触し得る部位、即ち測定用
試料が通液される部位であればよく、具体的には展開
膜、展開膜上の測定部位等が挙げられ、好ましくは測定
部位である。尚、本発明の感度増強剤を担持させる方法
としては、通常この分野で用いられる方法であればよ
く、例えば展開膜に上記した如き感度増強剤を含有する
溶液を、例えば塗布、滴下或いは噴霧等した後、これを
乾燥して物理的吸着により担持させる方法、例えば展開
膜等作製時に用いられる緩衝液や洗浄液等に本発明の感
度増強剤を溶解させ、これらを用いて展開膜を作製する
ことにより担持させる方法等が挙げられる。
When the sensitivity-enhancing agent of the present invention is used by being carried on an instrument for immunochromatography, the amount thereof is such as the place where it is carried, the type of sensitivity-enhancing agent used, the type of substance to be measured, and the type of substance to be used. Depending on the labeling substance, etc.,
For example, in the case of supporting it on the development membrane, sample labeling part, sample dropping part, etc. of the instrument for immunochromatography, the unit area (cm 2 )
The amount of sensitivity enhancer contained per
~ 10 mg, preferably 0.1 μg to 4 mg, more preferably
It is 1 to 800 μg. The supported area varies depending on the type and size of the immunochromatographic measuring instrument used and the amount of the measurement sample, but in the case of the developed membrane of the immunochromatographic measuring instrument, it is usually 10 to 10% of the total area. 60%, preferably 20-30%
1 to 30%, preferably 5 to 15%, in the case of the specimen dropping part,
Usually, it is 5 to 40% of the total area, preferably 10 to 20%. In addition, the site to be carried in the instrument for immunochromatography measurement may be a site that can come into contact with the measurement sample, that is, a site through which the measurement sample passes, and specifically, a development membrane, a development membrane. The above measurement site and the like can be mentioned, and the measurement site is preferable. The method of loading the sensitivity enhancer of the present invention may be any method commonly used in this field, for example, a solution containing the sensitivity enhancer as described above in the spreading film, for example, coating, dropping or spraying. After that, a method of drying it and supporting it by physical adsorption, for example, dissolving the sensitivity enhancer of the present invention in a buffer solution or a washing solution used at the time of preparation of a development film or the like, and preparing a development film using these And the like.

【0036】本発明に係るイムノクロマト測定法に用い
られるイムノクロマト測定法用試薬は、本発明の感度増
強剤以外に、例えば、測定対象物質である抗体に対する
抗原若しくは標識物質を担持してなる抗原等を含有して
いてもよい。尚、この際用いられる標識物質としては、
上記のイムノクロマト測定法用器具で用いられるものと
同じものが挙げられ、その濃度、調製方法等も同様に行
えばよい。更に、該反応試薬中には、緩衝剤(例えばト
リス緩衝剤、リン酸緩衝剤、ベロナール緩衝剤、ホウ酸
緩衝剤、グッド緩衝剤等)、安定化剤(例えばアルブミ
ン、グロブリン、水溶性ゼラチン、界面活性剤、糖類
等)、防腐剤(例えばサリチル酸、安息香酸、アジ化ナ
トリウム等)、その他この分野で用いられているもので
あって、共存する試薬等の安定性を阻害したり、抗原抗
体反応を阻害しないものを含有していてもよい。またそ
の使用濃度も、通常この分野で通常用いられる濃度範囲
で用いればよい。
The immunochromatographic assay reagent used in the immunochromatographic assay method according to the present invention contains, in addition to the sensitivity enhancer of the present invention, for example, an antigen against an antibody to be measured or an antigen carrying a labeling substance. It may be contained. The labeling substance used at this time is
The same materials as those used in the above-mentioned immunochromatography measuring instrument can be mentioned, and the concentration, the preparation method and the like may be the same. Furthermore, in the reaction reagent, a buffer (eg Tris buffer, phosphate buffer, veronal buffer, borate buffer, Good's buffer etc.), stabilizer (eg albumin, globulin, water-soluble gelatin, Surfactants, sugars, etc., preservatives (eg salicylic acid, benzoic acid, sodium azide, etc.) and others used in this field, such as inhibiting the stability of coexisting reagents, antigen-antibody You may contain the thing which does not inhibit reaction. Further, the concentration to be used may be within the concentration range usually used in this field.

【0037】本発明の感度増強剤を、各種試薬や試料中
に溶解させて用いる場合、その濃度は、抗原抗体反応が
なされる際の濃度として、通常0.1〜20w/v%、好ましく
は0.1〜10w/v%、より好ましくは0.1〜5w/v%となるよ
うに用いられる。
When the sensitivity enhancer of the present invention is used by dissolving it in various reagents or samples, its concentration is usually 0.1 to 20 w / v%, preferably 0.1 to 20 w / v% as a concentration at which an antigen-antibody reaction is carried out. It is used so as to be 10 w / v%, more preferably 0.1 to 5 w / v%.

【0038】また、本発明のイムノクロマト測定法を実
施するには、本発明に係る一般式[1]で示される基を
側鎖に有するポリマーを上記した如き濃度試薬中に共存
させて行うか、又は本発明に係る一般式[1]で示され
る基を側鎖に有するポリマーを上記した濃度イムノクロ
マト法用器具に担持させる以外は、自体公知のイムノク
ロマト測定法に於いて用いられる各種試薬を用い、自体
公知の操作法に準じて行えばよい。
To carry out the immunochromatographic assay method of the present invention, the polymer having the side chain of the group represented by the general formula [1] according to the present invention is coexisted in the concentration reagent as described above, or Alternatively, except that the polymer having a group represented by the general formula [1] in the side chain according to the present invention is carried on the above-mentioned instrument for concentration immunochromatography, various reagents used in the immunochromatographic measurement method known per se are used, It may be carried out according to a method known per se.

【0039】本発明のイムノクロマト測定法の測定対象
物質としては、例えば抗リン脂質抗体、抗トレポネーマ
抗体等の梅毒関連抗体である。
The substance to be measured by the immunochromatographic assay method of the present invention is an anti-phospholipid antibody, an anti-treponemal antibody or other syphilis-related antibody.

【0040】本発明の測定方法で用いられる本発明の感
度増強剤は、何れの測定対象物質であっても感度増強は
見られるが、測定対象物質によりその好ましいものが異
なる。例えば、測定対象物質が抗リン脂質抗体の場合、
例えば上記一般式[2]で表されるモノマーに基づく構
成単位からなるポリマー、上記一般式[2]で表される
モノマーに基づく構成単位とメタクリル酸ブチル由来の
モノマー単位からなるポリマー、上記一般式[2]で表
されるモノマーに基づく構成単位とメタクリル酸ベンジ
ル由来のモノマー単位からなるポリマー、上記一般式
[2]で表されるモノマーに基づく構成単位と上記一般
式[4]で表されるモノマーに基づく構成単位からなる
ポリマー等が好ましく挙げられ、中でも例えば上記一般
式[2]で表されるモノマーに基づく構成単位からなる
ポリマー、上記一般式[2]で表されるモノマーに基づ
く構成単位とメタクリル酸ブチル由来のモノマー単位か
らなるポリマー、上記一般式[2]で表されるモノマー
に基づく構成単位と上記一般式[4]で表されるモノマ
ーに基づく構成単位からなるポリマー等がより好ましい
ものとして挙げられる。また、例えば測定対象物質が抗
TP(Treponema Pallidum)抗体の場合、例えば上記一般
式[2]で表されるモノマーに基づく構成単位からなる
ポリマー、上記一般式[2]で表されるモノマーに基づ
く構成単位とメタクリル酸ブチル由来のモノマー単位か
らなるポリマー、上記一般式[2]で表されるモノマー
に基づく構成単位とメタクリル酸オクタデシル由来のモ
ノマー単位からなるポリマー、上記一般式[2]で表さ
れるモノマーに基づく構成単位とメタクリル酸由来のモ
ノマー単位からなるポリマー、上記一般式[2]で表さ
れるモノマーに基づく構成単位とメタクリル酸ベンジル
由来のモノマー単位からなるポリマー、上記一般式
[2]で表されるモノマーに基づく構成単位と上記一般
式[4]で表されるモノマーに基づく構成単位からなる
ポリマー等が好ましく挙げられ、中でも例えば上記一般
式[2]で表されるモノマーに基づく構成単位からなる
ポリマー、上記一般式[2]で表されるモノマーに基づ
く構成単位とメタクリル酸ブチル由来のモノマー単位か
らなるポリマー、上記一般式[2]で表されるモノマー
に基づく構成単位とメタクリル酸ベンジル由来のモノマ
ー単位からなるポリマー、上記一般式[2]で表される
モノマーに基づく構成単位と上記一般式[4]で表され
るモノマーに基づく構成単位からなるポリマー等がより
好ましいものとして挙げられる。
The sensitivity-enhancing agent of the present invention used in the measuring method of the present invention exhibits enhanced sensitivity in any substance to be measured, but the preferred substance varies depending on the substance to be measured. For example, when the substance to be measured is an antiphospholipid antibody,
For example, a polymer comprising a constitutional unit based on the monomer represented by the general formula [2], a polymer comprising a constitutional unit based on the monomer represented by the general formula [2] and a monomer unit derived from butyl methacrylate, the above general formula A polymer comprising a structural unit based on the monomer represented by [2] and a monomer unit derived from benzyl methacrylate, a structural unit based on the monomer represented by the general formula [2] and represented by the general formula [4]. Preferable examples include a polymer composed of a monomer-based constitutional unit. Among them, for example, a polymer composed of a monomer represented by the general formula [2], a polymer composed of a monomer represented by the general formula [2]. And a polymer comprising a monomer unit derived from butyl methacrylate, and a structural unit based on the monomer represented by the general formula [2]. Serial Formula polymers consisting of structural units based on a monomer represented by [4] can be mentioned as being preferred. Also, for example, if the substance to be measured is
In the case of a TP (Treponema Pallidum) antibody, for example, a polymer comprising a constitutional unit based on the monomer represented by the general formula [2], a constitutional unit based on the monomer represented by the general formula [2] and butyl methacrylate-derived Polymer consisting of monomer unit, constitutional unit based on monomer represented by general formula [2] and polymer consisting of monomer units derived from octadecyl methacrylate, constitutional unit based on monomer represented by general formula [2] and methacryl Polymers composed of acid-derived monomer units, polymers composed of monomer units represented by the general formula [2] and monomer units derived from benzyl methacrylate, and structures composed of monomer represented by the general formula [2] Preferable examples include polymers having a unit and a structural unit based on the monomer represented by the general formula [4]. Among them, for example, a polymer composed of a structural unit based on the monomer represented by the general formula [2], a polymer composed of a structural unit based on the monomer represented by the general formula [2] and a monomer unit derived from butyl methacrylate, A polymer comprising a structural unit based on the monomer represented by the general formula [2] and a monomer unit derived from benzyl methacrylate, a structural unit based on the monomer represented by the general formula [2] and represented by the general formula [4] More preferred are polymers and the like composed of structural units based on the above-mentioned monomers.

【0041】また、本発明のイムノクロマト測定法用器
具は、上記一般式[1]で示される基を側鎖に有するポ
リマーを、試料滴下部、試料標識部、展開膜(測定部)
等の試料検体が滴下、展開等通液する場所に担持させた
ものであり、好ましくは上記一般式[1]で示される基
を側鎖に有するポリマーを展開膜に添加したもの、上記
一般式[1]で示される基を側鎖に有するポリマーを試
料標識部に添加したもの、上記一般式[1]で示される
基を側鎖に有するポリマーを測定部に添加したもの等が
挙げられる。器具の構成要素の好ましい態様、具体例、
使用濃度等は、イムノクロマト測定法で用いられるもの
で述べた通りである。
Further, the instrument for immunochromatographic assay of the present invention comprises a polymer having a group represented by the above general formula [1] in a side chain, a sample dropping part, a sample labeling part, a developing film (measuring part).
Such as a sample supported on a place through which the sample passes, such as dropping and spreading, and preferably a polymer having a side chain having a group represented by the above general formula [1] added to the spreading film, the above general formula Examples thereof include those in which the polymer having the group represented by [1] in the side chain is added to the sample labeling part, and those in which the polymer having the group represented by the above general formula [1] in the side chain is added to the measurement part. Preferred embodiments of the components of the device, specific examples,
The concentration to be used and the like are as described in those used in the immunochromatographic measurement method.

【0042】以下実施例及び比較例によって本発明を説
明するが、本発明はこれによって限定されるものでな
い。
The present invention will be described below with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

【0043】また、実施例及び比較例に於けるMPCポ
リマーは、例えば特開2001-228149号公報記載の方法に
準じて以下の1種又は2種のモノマーから合成したポリ
マーを表す。 PMPC:2−(メタクリロイルオキシ)エチル−2’−
(トリメチルアンモニオ)エチルホスフェート(以下、M
PCモノマーと略記する。)からなるポリマー、分子
量;1030×103 PMB82:MPCモノマーとメタクリル酸ブチルとか
らなるコポリマー、分子量;600×103、MPCモノマー
とメタクリル酸ブチルの構成比;8:2 PMB82−1M:MPCモノマーとメタクリル酸ブチ
ルとからなるコポリマー、分子量;1210×103、MPC
モノマーとメタクリル酸ブチルの構成比;8:2 PMB37:MPCモノマーとメタクリル酸ブチルとか
らなるコポリマー、、分子量;93×103、MPCモノマ
ーとメタクリル酸ブチルの構成比;3:7 PME91:MPCモノマーとモノメチルエーテルポ
リエチレングリコールメタクリレート(一般式[4]に
於いてm=4のモノマー)とからなるコポリマー、分子
量;501×103、MPCモノマーとモノメチルエーテルポ
リエチレングリコールメタクリレートの構成比;9:1 PME73:MPCモノマーとモノメチルエーテルポ
リエチレングリコールメタクリレート(一般式[4]に
於いてm=4のモノマー)とからなるコポリマー、分子
量;138×103、MPCモノマーとモノメチルエーテルポ
リエチレングリコールメタクリレートの構成比;7:3 PMC1891:MPCモノマーとメタクリル酸オクタデ
シルとからなるポリマー、分子量;130×103、MPCモ
ノマーとメタクリル酸オクタデシルの構成比;9:1 PMC1882:MPCモノマーとメタクリル酸オクタデ
シルとからなるポリマー、分子量;43×103、MPCモ
ノマーとメタクリル酸オクタデシルの構成比;8:2 PMC1282:MPCモノマーとメタクリル酸ドデシル
とからなるポリマー、分子量;184×103、MPCモノマ
ーとメタクリル酸オクタデシルの構成比;8:2 PMBz82:MPCモノマーとメタクリル酸ベンジル
とからなるポリマー、分子量;240×103、MPCモノマ
ーとメタクリル酸オクタデシルの構成比;8:2
Further, the MPC polymer in Examples and Comparative Examples represents a polymer synthesized from the following one or two kinds of monomers according to the method described in JP 2001-228149 A, for example. PMPC: 2- (methacryloyloxy) ethyl-2'-
(Trimethylammonio) ethyl phosphate (hereinafter M
Abbreviated as PC monomer. ), A polymer having a molecular weight of 1030 × 10 3 PMB82: a copolymer of MPC monomer and butyl methacrylate, a molecular weight of 600 × 10 3 , the composition ratio of MPC monomer and butyl methacrylate; 8: 2 PMB82-1M: MPC monomer And butyl methacrylate copolymer, molecular weight: 1210 × 10 3 , MPC
Composition ratio of monomer to butyl methacrylate; 8: 2 PMB37: Copolymer composed of MPC monomer and butyl methacrylate, molecular weight; 93 × 10 3 , composition ratio of MPC monomer and butyl methacrylate; 3: 7 PME 4 91: Copolymer consisting of MPC monomer and monomethyl ether polyethylene glycol methacrylate (m = 4 monomer in the general formula [4]), molecular weight: 501 × 10 3 , composition ratio of MPC monomer and monomethyl ether polyethylene glycol methacrylate; 9: 1 PME 4 73: MPC monomer copolymer consisting of a monomethyl ether of polyethylene glycol methacrylate (monomer of the general formula in [4] m = 4), molecular weight; 138 × 10 3, MPC monomer and monomethyl ether of polyethylene glycol methacrylate Total composition; 7: 3 PMC 18 91: MPC monomer and polymer consisting of octadecyl methacrylate, molecular weight; 130 × 10 3, MPC monomer composition ratio of octadecyl methacrylate; 9: 1 PMC 18 82: MPC monomer and methacrylic acid Polymer composed of octadecyl, molecular weight; 43 × 10 3 , composition ratio of MPC monomer and octadecyl methacrylate; 8: 2 PMC 12 82: Polymer composed of MPC monomer and dodecyl methacrylate, molecular weight; 184 × 10 3 , MPC monomer And the composition ratio of octadecyl methacrylate; 8: 2 PMBz82: Polymer composed of MPC monomer and benzyl methacrylate, molecular weight; 240 × 10 3 , composition ratio of MPC monomer and octadecyl methacrylate; 8: 2

【0044】実施例1 (1)TP(Treponema Pallidum、トレポネーマパリダム)
抗原及びリン脂質抗原の標識 先ず、TP抗原(1.0mg/ml)8μlを遠心管に分注し、次
いでそこに平均粒径35nm、Amax=1.2の金コロイド懸濁
液5mlを注ぎ室温で30分間反応させた後、遠心分離(800
0G、15分間)して金コロイド標識TP抗原を回収した。
尚、TP抗原は、公知のリコンビナント抗原作製法(Infe
ction and Immunity, volume 54, p500-506, Michael
V. Norgard)に従って作製したものを用いた。
Example 1 (1) TP (Treponema Pallidum, Treponema pallidum)
Labeling of Antigen and Phospholipid Antigen First, 8 μl of TP antigen (1.0 mg / ml) was dispensed into a centrifuge tube, and then 5 ml of gold colloidal suspension having an average particle size of 35 nm and A max = 1.2 was poured into the tube at room temperature for 30 minutes. Centrifuge (800
The colloidal gold labeled TP antigen was recovered by performing 0 G for 15 minutes.
The TP antigen is a known recombinant antigen preparation method (Infe
ction and Immunity, volume 54, p500-506, Michael
V. Norgard) was used.

【0045】リン脂質抗原液は、5mg/mlカルジオライピ
ン(牛心臓由来、シグマ社製)エタノール溶液、10mg/m
l フォスファチジルコリン(卵黄由来、キューピー社
製)エタノール溶液をそれぞれ2ml、0.5ml(重量比2:
1)ずつ混合したものを調製して用いた。
Phospholipid antigen solution is 5 mg / ml cardiolipin (derived from bovine heart, manufactured by Sigma) ethanol solution, 10 mg / m
l Phosphatidylcholine (from egg yolk, manufactured by Kewpie) 2 ml and 0.5 ml of ethanol solution (weight ratio 2:
1) Each mixture was prepared and used.

【0046】調製したリン脂質抗原液0.25mlに前処理済
み金コロイド懸濁液(平均粒径35nm、Amax=20.0)0.8m
lを添加し、室温で2時間転倒混和した。その後、ブロッ
キング液(1%BSA、2%スクロースを含む50mM モルホ
リノエタンスルホン酸(MES)緩衝液)30mlを加え15分間
放置し、遠心分離(8000G、15分間)して金コロイド標
識リン脂質抗原を回収した。
Pretreated gold colloidal suspension (average particle size 35 nm, A max = 20.0) 0.8 m in 0.25 ml of the prepared phospholipid antigen solution
l was added and mixed by inversion at room temperature for 2 hours. After that, add 30 ml of blocking solution (50 mM morpholinoethanesulfonic acid (MES) buffer containing 1% BSA and 2% sucrose), leave it for 15 minutes, and centrifuge (8000G, 15 minutes) to collect gold colloid-labeled phospholipid antigen. Recovered.

【0047】(2)検体滴下部の作製 先ず、ガラス繊維シートを、0.5%BSA及び1% スクロー
スを含む25mMリン酸緩衝液にて15分間マスキングし、さ
らに1% ポリ(1−ビニルピロリドンコビニルアセテー
ト)[poly(1-vinylpyrrolidone-co-vinyl acetate)、
以下、poly-PAと略記する。(アルドリッチ社製)]及び1
% スクロースを含む25mMリン酸緩衝液で洗浄し乾燥
させ、検体滴下部とした。
(2) Preparation of specimen dropping part First, a glass fiber sheet was masked with 25 mM phosphate buffer containing 0.5% BSA and 1% sucrose for 15 minutes, and further 1% poly (1-vinylpyrrolidonecovinyl) was used. Acetate) [poly (1-vinylpyrrolidone-co-vinyl acetate),
Hereinafter, abbreviated as poly-PA. (Manufactured by Aldrich)] and 1
It was washed with a 25 mM phosphate buffer solution containing% sucrose and dried to make a sample dropping part.

【0048】(3)検体標識部の作製 (1)で作製した金コロイド標識TP抗原をAmax=1.3と
なるように、金コロイド標識リン脂質抗原をAmax=1.4
となるように添加した、1% poly-PA及び1%スクロー
スを含む50mM MES緩衝液を、検体滴下部に5mm×200mm当
り500μl含浸させた後、50℃で乾燥し、検体標識部とし
た。
(3) Preparation of specimen labeling part The colloidal gold-labeled phospholipid antigen prepared in (1) has A max = 1.3, and the gold colloid-labeled phospholipid antigen has A max = 1.4.
The sample dropping part was impregnated with 500 μl per 5 mm × 200 mm of 50 mM MES buffer solution containing 1% poly-PA and 1% sucrose, which was added so as to obtain a sample labeling part.

【0049】(4)展開膜の作製 リコンビナントTP抗原(1.0mg/ml)40μl及び10% ス
クロースを含む250mMリン酸緩衝液20μlを混合したもの
をTP抗原液とした。
(4) Preparation of spreading film A mixture of 40 μl of recombinant TP antigen (1.0 mg / ml) and 20 μl of 250 mM phosphate buffer containing 10% sucrose was used as a TP antigen solution.

【0050】また、5mg/mlカルジオライピン(牛心臓由
来、シグマ社製)エタノール溶液125μl、10mg/mlフォ
スファチジルコリン(卵黄由来、日本油脂(株)製)エ
タノール溶液250μl及び20mg/mlコレステロール(和光
純薬工業(株)製)エタノール溶液125μlからなるリン
脂質抗原溶液をエバポレーターで溶媒留去し脂質薄膜を
形成させた。2時間真空乾燥した後、該脂質薄膜に100mM
ホウ酸緩衝液 500μlを加えて懸濁し、該懸濁液を更に
超音波処理したものをリポソーム懸濁液とした。次い
で、TP抗原液とリポソーム懸濁液を夫々ナイロン膜(20m
m×200mm)の別の部分へ0.25μl/cmで線塗布し(200mm)、
50℃で5分間乾燥した。次いで、1%BSA及び2%スクロ
ースを含む50mM MES緩衝液中に15分間浸した。さらに、
1%Poly-PA、2%スクロースを含む50mM MES緩衝液に
て2回洗浄した後、50℃で15分間乾燥したものを、抗TP
抗体・抗リン脂質抗体同時検出用の測定部を有する展開
膜とした。
Also, 125 mg of a 5 mg / ml cardiolipin (derived from beef heart, manufactured by Sigma) ethanol solution, 10 mg / ml phosphatidylcholine (derived from egg yolk, manufactured by NOF Corporation), 250 μl and 20 mg / ml cholesterol (sum) A phospholipid antigen solution consisting of 125 μl of an ethanol solution manufactured by Kojunkaku Co., Ltd. was distilled off with an evaporator to form a lipid thin film. After vacuum drying for 2 hours, 100 mM was applied to the lipid thin film.
500 μl of borate buffer was added and suspended, and the suspension was further sonicated to obtain a liposome suspension. Then, the TP antigen solution and the liposome suspension were each applied to a nylon membrane (20 m
m × 200mm) to another part with 0.25μl / cm wire coating (200mm),
It was dried at 50 ° C for 5 minutes. Then, it was immersed in 50 mM MES buffer containing 1% BSA and 2% sucrose for 15 minutes. further,
After washing twice with 50 mM MES buffer containing 1% Poly-PA and 2% sucrose, and then drying at 50 ° C for 15 minutes, anti-TP
The developed membrane was equipped with a measurement unit for simultaneous detection of antibody and antiphospholipid antibody.

【0051】(5)測定用器具の組立て 両面テープをラミネートしたポリエチレンテレフタレー
ト(PET)シート(8cm×20cm)の下端より1.2cmの部
位に(4)で作製した展開膜を貼り付け、該展開膜上端
に1mm重なるように吸収部としてガラス繊維シート(4c
m×20cm)を貼り合わせた。次いで、展開膜下端に1mm重
なるように検体標識部を貼り、最後に検体滴下部をPE
Tシート下端に検体標識部と重ねて張り合わせたシート
を4mm幅に切断したものをTP抗体・リン脂質抗体検出用
器具とした。得られた器具は除湿条件下にて室温で保存
した。模式図を図1に示す。尚、図1に於いて各数字は
夫々以下のものを示す。
(5) Assembling the measuring instrument The polyethylene terephthalate (PET) sheet (8 cm × 20 cm) laminated with the double-sided tape was attached with the spreading film prepared in (4) at a position 1.2 cm from the lower end, and the spreading film was applied. The glass fiber sheet (4c
m × 20 cm) were pasted together. Next, attach the sample labeling part so that it overlaps the bottom edge of the developed film by 1 mm, and finally attach the sample dropping part with PE.
A sheet with a specimen labeling portion laminated on the lower end of the T sheet and cut into a 4 mm width was used as an instrument for detecting TP antibody / phospholipid antibody. The obtained device was stored at room temperature under dehumidifying conditions. A schematic diagram is shown in FIG. In addition, in FIG. 1, each numeral indicates the following respectively.

【0052】 1:支持体 2:検体滴下部 3:検体標識部(標識リン脂質抗原及び標識梅毒抗原を
保持した部分) 4:展開膜 5:リン脂質抗原が固定化された担持部(第1測定部) 6:TP抗原担持部(第2測定部) 7:液体吸収部
1: Support 2: Specimen dropping part 3: Specimen labeling part (portion holding labeled phospholipid antigen and labeled syphilis antigen) 4: Development membrane 5: Supporting part to which phospholipid antigen is immobilized (first) Measurement part) 6: TP antigen carrying part (second measurement part) 7: Liquid absorption part

【0053】(6)測定 (5)で作製した試験用具の検体滴下部に、表1に記載
の各種濃度の各種MPCポリマーを0.5〜3%添加した検体50
〜100μlを滴下して、15分放置した。その後、測定ライ
ンの有無で抗TP抗体・抗リン脂質抗体の測定を行った。
その結果を表1に示す。尚、表中、+は着色をしている
もの、+wは薄い着色をしているもの、±は着色をして
いると思われるもの、×は着色をしていないものを表
す。
(6) Specimen 50 in which 0.5 to 3% of various concentrations of MPC polymers shown in Table 1 were added to the specimen dropping part of the test tool prepared in the measurement (5)
-100 μl was added dropwise and left for 15 minutes. After that, the anti-TP antibody / anti-phospholipid antibody was measured with or without the measurement line.
The results are shown in Table 1. In the table, + means colored, + w means lightly colored, ± means colored, and x means not colored.

【0054】比較例1 検体にMPCポリマーを添加する代わりに、ポリビニルピ
ロリドン(PVP)、ポリビニルアルコール(PVA)又はポ
リエチレングリコール(PEG)を添加した以外は実施例
1と同様に実験を行った。その結果を表1に併せて示
す。
Comparative Example 1 An experiment was conducted in the same manner as in Example 1 except that polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA) or polyethylene glycol (PEG) was added instead of adding the MPC polymer to the sample. The results are also shown in Table 1.

【0055】[0055]

【表1】 [Table 1]

【0056】この結果から、MPCポリマーの種類によ
りその効果は多少異なるものの、試料に各種MPCポリ
マーを添加することにより、抗TP抗体又は/及び抗リン
脂質抗体の判定部における判定ラインの増強が認めら
れ、MPCポリマー無添加の試料では検出できなかった
弱陽性検体が検出できるようになることが分かった。
From these results, although the effect is slightly different depending on the type of MPC polymer, by adding various MPC polymers to the sample, the enhancement of the determination line in the determination part of the anti-TP antibody and / or the antiphospholipid antibody was recognized. It was found that weak positive specimens which could not be detected in the sample without MPC polymer added can be detected.

【0057】一方、PVP、PVA、PEGを添加しても、弱陽
性検体を検出することはできなかった。
On the other hand, even if PVP, PVA or PEG was added, a weakly positive sample could not be detected.

【0058】実施例2 さらに、MPCポリマーを添加する場所を変えて以下の実
験を行った。 (1)MPCポリマーを検体滴下部作製時の洗浄液に添加
した場合 実施例1(2)で検体滴下部を作製する際に、1% poly
-PA(アルドリッチ社製)及び1% スクロースを含む25m
Mリン酸緩衝液中に、表1に記載の各種MPCポリマーを
0.5〜3%添加させた以外は、実施例1と同様に試験用具
を作製した。また、測定は、検体にMPCポリマーを添加
しなかった以外は実施例1と同様にして、実験を行っ
た。
Example 2 Further, the following experiment was conducted by changing the place where the MPC polymer was added. (1) When MPC polymer was added to the cleaning liquid used for preparing the sample dropping part When the sample dropping part was prepared in Example 1 (2), 1% poly
-25m containing PA (made by Aldrich) and 1% sucrose
Various MPC polymers listed in Table 1 were added to M phosphate buffer.
A test tool was produced in the same manner as in Example 1 except that 0.5 to 3% was added. The measurement was conducted in the same manner as in Example 1 except that the MPC polymer was not added to the sample.

【0059】(2)MPCポリマーを検体標識部作製時の
緩衝液に添加した場合 実施例1(3)で検体標識部を作製する際に、金コロイ
ド標識TP抗原及び金コロイド標識リン脂質抗原を所定濃
度含有する1% poly-PA(アルドリッチ社製)及び1% ス
クロースを含む50mM MES緩衝液に、表1に記載の各種MP
Cポリマーを0.5〜3%添加させた以外は、実施例1と同様
に試験用具を作製した。また、測定は、検体にMPCポリ
マーを添加しなかった以外は実施例1と同様に行った。 (3)MPCポリマーを展開膜作製時の洗浄溶液に添加し
た場合 実施例1(4)で展開膜を作製する際に、1% poly-PA
(アルドリッチ社製)及び2% スクロースを含む50mM ME
S緩衝液に、表1に記載の各種濃度の各種MPCポリマーを
0.5〜3%添加させた以外は、実施例1と同様に試験用具
を作製した。また、測定は、検体にMPCポリマーを添加
しなかった以外は実施例1と同様に行った。
(2) When the MPC polymer is added to the buffer solution used in the preparation of the sample labeled part When the sample labeled part is prepared in Example 1 (3), the gold colloid labeled TP antigen and the gold colloid labeled phospholipid antigen are added. The various MPs listed in Table 1 were added to 50 mM MES buffer containing 1% poly-PA (manufactured by Aldrich) and 1% sucrose at a predetermined concentration.
A test tool was produced in the same manner as in Example 1 except that 0.5 to 3% of C polymer was added. The measurement was performed in the same manner as in Example 1 except that the MPC polymer was not added to the sample. (3) When MPC polymer was added to the cleaning solution used in the development film preparation. When the development film was prepared in Example 1 (4), 1% poly-PA was used.
50 mM ME containing Aldrich and 2% sucrose
S MP buffer with various concentrations of various MPC polymers listed in Table 1
A test tool was produced in the same manner as in Example 1 except that 0.5 to 3% was added. The measurement was performed in the same manner as in Example 1 except that the MPC polymer was not added to the sample.

【0060】上記した如きMPCポリマー添加場所を変え
た実験を行った結果、表1と同じ結果が得られた。
As a result of conducting an experiment in which the MPC polymer addition place was changed as described above, the same results as in Table 1 were obtained.

【0061】よって、MPCポリマーは、試料中にのみで
はなく、イムノクロマト測定用器具の試料が通液する場
所の何れかに添加されることでも、その感度増強効果を
発揮することが分かった。
Therefore, it was found that the MPC polymer exerts its sensitivity-enhancing effect not only in the sample but also when it is added to any place where the sample of the instrument for immunochromatographic measurement passes.

【0062】[0062]

【発明の効果】以上述べたことから明らかな如く、本発
明は、従来公知の梅毒関連抗体を測定対象物質とするイ
ムノクロマト測定法で用いられていた感度増強剤に比較
して、著しく効果が優れているものを提供するものであ
り、該感度増強剤を用いるイムノクロマト測定法によ
り、更に精度の高い測定を可能にするものである。
EFFECTS OF THE INVENTION As is clear from the above description, the present invention is remarkably excellent in effect as compared with the sensitivity enhancer used in the immunochromatographic assay method using a conventionally known syphilis-related antibody as a substance to be measured. The present invention also provides a method for immunochromatography using the sensitivity enhancer, which enables more accurate measurement.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明のイムノクロマト測定法用器具の模式図
を表す。
FIG. 1 shows a schematic diagram of an instrument for immunochromatographic assay of the present invention.

【符号の説明】[Explanation of symbols]

1:支持体 2:検体滴下部 3:検体標識部(標識リン脂質抗原及び標識梅毒抗原を
保持した部分) 4:展開膜 5:リン脂質抗原が固定化された担持部(第1測定部) 6:TP抗原担持部(第2測定部) 7:液体吸収部
1: Support 2: Specimen dropping part 3: Specimen labeling part (portion holding labeled phospholipid antigen and labeled syphilis antigen) 4: Development membrane 5: Carrying part on which phospholipid antigen is immobilized (first measurement part) 6: TP antigen carrying part (second measuring part) 7: liquid absorbing part

───────────────────────────────────────────────────── フロントページの続き (72)発明者 木田 正章 兵庫県尼崎市高田町6番1号 臨薬研究所 内   ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Masaaki Kida             6-1 Takadacho Amagasaki City, Hyogo Pref.             Within

Claims (14)

【特許請求の範囲】[Claims] 【請求項1】下記一般式[1] 【化1】 (式中、R〜Rは夫々独立して水素原子又は水酸基
を有していてもよいアルキル基を示し、Rはアルキレ
ン基を示す。)で表される基を側鎖に有するポリマーを
含んでなる、梅毒関連抗体を測定対象物質とするイムノ
クロマト測定法用感度増強剤。
1. The following general formula [1]: (In the formula, R 1 to R 3 each independently represent a hydrogen atom or an alkyl group which may have a hydroxyl group, and R 4 represents an alkylene group.) A polymer having a side chain. A sensitivity enhancer for immunochromatographic assay, which comprises a syphilis-related antibody as a measurement target substance.
【請求項2】ポリマーが、下記一般式[2] 【化2】 (式中、Rは、置換基を有していてもよく且つ鎖中に
酸素原子を有していてもよいアルキレン基を示し、R
は水素原子又はメチル基を示し、Xは酸素原子又は−N
H−基を示し、R〜Rは前記に同じ。)で表される
モノマーに基づく構成単位を有するものである、請求項
1に記載の感度増強剤。
2. The polymer has the following general formula [2]: (In the formula, R 5 represents an alkylene group which may have a substituent and may have an oxygen atom in the chain, and R 5
Represents a hydrogen atom or a methyl group, X represents an oxygen atom or -N
H-group is shown, and R 1 to R 4 are the same as above. The sensitivity enhancing agent according to claim 1, which has a structural unit based on the monomer represented by the formula (1).
【請求項3】ポリマーが、下記一般式[2] 【化3】 (式中、R〜R及びXは前記に同じ。)で示される
モノマーに基づく構成単位と、アクリル酸又はアクリル
酸エステル、メタクリル酸又はメタクリル酸エステル、
アクリルアミド又はそのN置換体、メタクリルアミド又
はそのN置換体、或いはスチレン又はその誘導体から選
ばれるモノマーに基づく構成単位を有するコポリマーで
ある、請求項2に記載の感度増強剤。
3. The polymer has the following general formula [2]: (In the formula, R 1 to R 6 and X are the same as above.), A structural unit based on the monomer, acrylic acid or an acrylic acid ester, methacrylic acid or a methacrylic acid ester,
The sensitivity enhancer according to claim 2, which is a copolymer having a constitutional unit based on a monomer selected from acrylamide or an N-substituted product thereof, methacrylamide or an N-substituted product thereof, or styrene or a derivative thereof.
【請求項4】前記一般式[2]で表されるモノマーに基
づく構成単位が、下記一般式[3] 【化4】 で表されるモノマーに基づく構成単位である、請求項2
又は3に記載の感度増強剤。
4. A constitutional unit based on the monomer represented by the general formula [2] has the following general formula [3]: A structural unit based on a monomer represented by:
Or the sensitivity enhancer according to 3.
【請求項5】アクリル酸エステルが、アルキルアクリレ
ート又はアラルキルアクリレートである、請求項3又は
4に記載の感度増強剤。
5. The sensitivity enhancer according to claim 3, wherein the acrylic ester is an alkyl acrylate or an aralkyl acrylate.
【請求項6】メタクリル酸エステルが、アルキルメタク
リレート又はアラルキルメタクリレートである、請求項
3又は4に記載の感度増強剤。
6. The sensitivity enhancer according to claim 3, wherein the methacrylic acid ester is alkyl methacrylate or aralkyl methacrylate.
【請求項7】メタクリル酸エステル由来のモノマー単位
が、メタクリル酸ステアリル、メタクリル酸ベンジル、
メタクリル酸ブチル、メタクリル酸ドデシル、メタクリ
ル酸オクタデシル又はN,N,N-トリメチルアンモニウム−
2−ヒドロキシプロピルメタクリレートクロリド由来の
もの、或いは下記一般式[4] 【化5】 (式中、mは1〜100を表す。)で表されるモノマーに
基づく構成単位である、請求項3又は4に記載の感度増
強剤。
7. A monomer unit derived from a methacrylic acid ester is stearyl methacrylate, benzyl methacrylate,
Butyl methacrylate, dodecyl methacrylate, octadecyl methacrylate or N, N, N-trimethylammonium-
Derived from 2-hydroxypropyl methacrylate chloride or represented by the following general formula [4] (In the formula, m represents 1 to 100.) The sensitivity enhancer according to claim 3 or 4, which is a constitutional unit based on a monomer represented by the formula.
【請求項8】アクリルアミドのN置換体が、N−アルキ
ルアクリルアミド又はN−アラルキルアクリルアミドで
ある、請求項3又は4に記載の感度増強剤。
8. The sensitivity enhancer according to claim 3, wherein the N-substituted acrylamide is N-alkylacrylamide or N-aralkylacrylamide.
【請求項9】メタクリルアミドのN置換体が、N−アル
キルメタクリルアミド又はN−アラルキルメタクリルア
ミドである、請求項3又は4に記載の感度増強剤。
9. The sensitivity enhancer according to claim 3, wherein the N-substituted methacrylamide is N-alkyl methacrylamide or N-aralkyl methacrylamide.
【請求項10】共重合体中の、下記一般式[2] 【化6】 (式中、R〜R及びXは前記に同じ。)で示される
モノマーに基づく構成単位の比率が20%以上100%未満
である、請求項2〜9の何れかに記載の感度増強剤。
10. A copolymer represented by the following general formula [2]: (In the formula, R 1 to R 6 and X are the same as the above.) The ratio of the constituent unit based on the monomer is 20% or more and less than 100%, and the sensitivity enhancement according to any one of claims 2 to 9. Agent.
【請求項11】ポリマーの分子量が、10,000〜1,000,00
0である、請求項1〜10の何れかに記載の感度増強
剤。
11. The molecular weight of the polymer is 10,000 to 1,000,00.
The sensitivity enhancer according to any one of claims 1 to 10, which is 0.
【請求項12】請求項1〜11の何れかに記載の感度増
強剤の存在下で抗原抗体反応を行わせることを特徴とす
る、梅毒関連抗体を測定対象物質とするイムノクロマト
測定法。
12. An immunochromatographic assay method using a syphilis-related antibody as a substance to be assayed, which comprises causing an antigen-antibody reaction in the presence of the sensitivity enhancer according to any one of claims 1 to 11.
【請求項13】請求項1〜11の何れかに記載の感度増
強剤を含んでなる、梅毒関連抗体を測定対象物質とする
イムノクロマト測定法用器具。
13. An instrument for immunochromatographic assay, which comprises the syphilis-related antibody as a substance to be measured, which comprises the sensitivity enhancer according to any one of claims 1 to 11.
【請求項14】請求項1〜11の何れかに記載の感度増
強剤を測定部に担持してなる、梅毒関連抗体を測定対象
物質とするイムノクロマト測定法用器具。
14. An instrument for immunochromatographic assay, wherein the sensitivity enhancing agent according to any one of claims 1 to 11 is carried on a measuring section, and an syphilis-related antibody is a substance to be measured.
JP2002151415A 2002-05-24 2002-05-24 Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method Expired - Lifetime JP3911200B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002151415A JP3911200B2 (en) 2002-05-24 2002-05-24 Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002151415A JP3911200B2 (en) 2002-05-24 2002-05-24 Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method

Publications (2)

Publication Number Publication Date
JP2003344413A true JP2003344413A (en) 2003-12-03
JP3911200B2 JP3911200B2 (en) 2007-05-09

Family

ID=29769013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002151415A Expired - Lifetime JP3911200B2 (en) 2002-05-24 2002-05-24 Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method

Country Status (1)

Country Link
JP (1) JP3911200B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006189317A (en) * 2005-01-06 2006-07-20 Sysmex Corp Testing element for immunochromatographic method
WO2007007443A1 (en) 2005-07-11 2007-01-18 Wako Pure Chemical Industries, Ltd. Novel polymer and method of measuring cholesterol therewith
WO2007066731A1 (en) * 2005-12-07 2007-06-14 Sekisui Medical Co., Ltd. Reagent for assaying antiphospholipid antibody and reagent for assaying anti-treponema pallidum antibody
JP2007155624A (en) * 2005-12-07 2007-06-21 Sekisui Chem Co Ltd Anti-Treponema / Paridum antibody measurement reagent
JP2007155623A (en) * 2005-12-07 2007-06-21 Sekisui Chem Co Ltd Antiphospholipid antibody measurement reagent
JP2009516199A (en) * 2005-11-18 2009-04-16 アメリカ合衆国 Modified cardiolipin and uses thereof
JP2009222692A (en) * 2008-03-19 2009-10-01 Jsr Corp Signal enhancer of immunochemical reaction, and immunological measurement method
WO2010007734A1 (en) 2008-07-14 2010-01-21 田中貴金属工業株式会社 Developing solution for immunochromatography, and measurement method using same
US8778619B2 (en) 2005-11-18 2014-07-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
WO2016068225A1 (en) * 2014-10-31 2016-05-06 日油株式会社 Sensitizer for immunochromatographic measuring method with dengue virus as substance to be measured, and measuring method using sensitizer
WO2018181263A1 (en) * 2017-03-27 2018-10-04 日本ハム株式会社 Substance that prevents antigen-antibody reaction inhibition by body fluid
KR20200102420A (en) 2017-12-22 2020-08-31 가부시키가이샤산와카가쿠켄큐쇼 Immunochromatography device
WO2022091923A1 (en) * 2020-10-29 2022-05-05 日油株式会社 Sensitizer for immunochromatographic assays, and assay
WO2022124270A1 (en) * 2020-12-11 2022-06-16 日油株式会社 Sensitizer for immunochromatographic assays, and assay
WO2023054340A1 (en) * 2021-09-30 2023-04-06 日油株式会社 Nucleic acid amplification promoter and test method using same
WO2024166945A1 (en) * 2023-02-09 2024-08-15 学校法人 川崎学園 Sensitizer for immunochromatographic measurements targeting hepatitis virus, specimen diluent for immunochromatographic measurements, immunochromatographic measurement method, tool for immunochromatographic measurements and test kit for hepatitis virus

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006189317A (en) * 2005-01-06 2006-07-20 Sysmex Corp Testing element for immunochromatographic method
WO2007007443A1 (en) 2005-07-11 2007-01-18 Wako Pure Chemical Industries, Ltd. Novel polymer and method of measuring cholesterol therewith
JP2011237443A (en) * 2005-11-18 2011-11-24 Usa Government Modified cardiolipin and method for using the same
US8906603B2 (en) 2005-11-18 2014-12-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Modified cardiolipin and uses therefor
US9081009B2 (en) 2005-11-18 2015-07-14 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
US8778619B2 (en) 2005-11-18 2014-07-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Oxidized cardiolipin and uses to detect cardiolipin antibodies
JP2009516199A (en) * 2005-11-18 2009-04-16 アメリカ合衆国 Modified cardiolipin and uses thereof
JP4837743B2 (en) * 2005-11-18 2011-12-14 アメリカ合衆国 Modified cardiolipin and uses thereof
JP2007155624A (en) * 2005-12-07 2007-06-21 Sekisui Chem Co Ltd Anti-Treponema / Paridum antibody measurement reagent
AU2006323739B2 (en) * 2005-12-07 2012-05-03 Nof Corporation Reagent for assaying antiphospholipid antibody and reagent for assaying anti-treponema pallidum antibody
CN102565397A (en) * 2005-12-07 2012-07-11 积水医疗株式会社 Method for preventing serum interference and improving storage stability of reagent of anti-phospholipid antibody
JP2007155623A (en) * 2005-12-07 2007-06-21 Sekisui Chem Co Ltd Antiphospholipid antibody measurement reagent
KR101440938B1 (en) * 2005-12-07 2014-09-17 세키스이 메디칼 가부시키가이샤 Reagent for assaying antiphospholipid antibody and reagent for assaying anti-treponema pallidum antibody
WO2007066731A1 (en) * 2005-12-07 2007-06-14 Sekisui Medical Co., Ltd. Reagent for assaying antiphospholipid antibody and reagent for assaying anti-treponema pallidum antibody
JP2009222692A (en) * 2008-03-19 2009-10-01 Jsr Corp Signal enhancer of immunochemical reaction, and immunological measurement method
WO2010007734A1 (en) 2008-07-14 2010-01-21 田中貴金属工業株式会社 Developing solution for immunochromatography, and measurement method using same
WO2016068225A1 (en) * 2014-10-31 2016-05-06 日油株式会社 Sensitizer for immunochromatographic measuring method with dengue virus as substance to be measured, and measuring method using sensitizer
JPWO2016068225A1 (en) * 2014-10-31 2017-09-14 日油株式会社 Sensitizer for immunochromatographic assay using dengue virus as a substance to be measured and assay using the sensitizer
WO2018181263A1 (en) * 2017-03-27 2018-10-04 日本ハム株式会社 Substance that prevents antigen-antibody reaction inhibition by body fluid
JPWO2018181263A1 (en) * 2017-03-27 2019-06-27 日本ハム株式会社 Substance that prevents antigen-antibody reaction inhibition by body fluid
US11719695B2 (en) 2017-03-27 2023-08-08 Nh Foods Ltd Immunoassay method to prevent inhibition of antigen-antibody binding interactions in mucosal fluids
KR20200102420A (en) 2017-12-22 2020-08-31 가부시키가이샤산와카가쿠켄큐쇼 Immunochromatography device
US11619630B2 (en) 2017-12-22 2023-04-04 Sanwa Kagaku Kenkyusho Co., Ltd. Immunochromatography device
WO2022091923A1 (en) * 2020-10-29 2022-05-05 日油株式会社 Sensitizer for immunochromatographic assays, and assay
WO2022124270A1 (en) * 2020-12-11 2022-06-16 日油株式会社 Sensitizer for immunochromatographic assays, and assay
EP4261541A4 (en) * 2020-12-11 2024-10-23 NOF Corporation SENSITIZER FOR IMMUNOCHROMATOGRAPHIC TESTS AND TEST
WO2023054340A1 (en) * 2021-09-30 2023-04-06 日油株式会社 Nucleic acid amplification promoter and test method using same
WO2024166945A1 (en) * 2023-02-09 2024-08-15 学校法人 川崎学園 Sensitizer for immunochromatographic measurements targeting hepatitis virus, specimen diluent for immunochromatographic measurements, immunochromatographic measurement method, tool for immunochromatographic measurements and test kit for hepatitis virus

Also Published As

Publication number Publication date
JP3911200B2 (en) 2007-05-09

Similar Documents

Publication Publication Date Title
CA2318459C (en) Neutralization of polycations in a chromatographic device for whole blood use
JP2003344413A (en) Sensitivity enhancer for immunochromatography measurement method, measurement method and instrument for measurement method
EP0195624B1 (en) Fluorescent labels and labeled species and their use in analytical elements and determinations
US7635571B2 (en) Amplified signal in binding assays
EP3845900B1 (en) Chromatography kit, and chromatography method
JP2006091023A (en) Integrated package holder device for immuno-chromatography assay of flow-through or dipstick type
WO2000031538A1 (en) Improved lateral flow assays
JP4060380B2 (en) Chemiluminescent compositions containing cationic surfactants or polymers and 4'-hydroxyacetanilide, test kits and their use in analytical methods
CN101784897A (en) Reagents, kits and methods for detecting biological molecules by energy transfer from an activated chemiluminescent substrate to an energy acceptor dye
EP0348211A2 (en) Visual discrimination qualitative enzyme assay
JP2001021563A (en) Specific bonding body
EP0848819B1 (en) Analytical element and method for the determination of a specific binding ligand using a vanadium bromoperoxidase as a signal-generating enzyme
EP0684473A2 (en) Immunoassay elements comprising polymers containing vanadium IV (V (+4)) ions
Ramesh Kumar et al. Sukumaran (2014) Anti-human IgG-horseradish peroxidase conjugate preparation and its use in ELISA and western blotting experiments
JPH03186761A (en) Dry type immunoassay analysis element containing signal dispersed bead
JPH11352127A (en) Non-specific adsorption preventing agent
JP2001021560A (en) Immunity chromatography
JP2002040026A (en) Inspection piece for enzyme immuno-chromatograph and inspection method
JP2002243743A (en) Method of detecting tested substance
CA1336163C (en) Enzyme quantitation wicking assay
JP2002202309A (en) Immunological test method
JP3727661B6 (en) Analytical elements and methods for determination of specific binding ligands using vanadium bromoperoxidase as a signal generating enzyme
JP2001074738A (en) Immunochormatograph method
JP2002031639A (en) Immunoassay method
JP2002122598A (en) Test piece and expansion composition for immunoenzymo chromatography

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050204

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20070116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20070126

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3911200

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100202

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100202

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110202

Year of fee payment: 4

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110202

Year of fee payment: 4

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110202

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120202

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130202

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130202

Year of fee payment: 6

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term